Related references
Note: Only part of the references are listed.Protective effects of pogostone from Pogostemonis Herba against ethanol-induced gastric ulcer in rats
Haiming Chen et al.
FITOTERAPIA (2015)
25-O-acetyl-23,24-dihydro-cucurbitacin F induces cell cycle G2/M arrest and apoptosis in human soft tissue sarcoma cells
Birgit Lohberger et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
Development and validation of an LC-ESI-MS/MS method for the quantitation of hemslecin A in rhesus monkey plasma and its application in pharmacokinetics
Min Bai et al.
BIOMEDICAL CHROMATOGRAPHY (2014)
Three new cucurbitane triterpenoids from Hemsleya penxianensis and their cytotoxic activities
Xiaoting Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Cytotoxic cucurbitane triterpenoids isolated from the rhizomes of Hemsleya amabilis
Xu-Bing Chen et al.
FITOTERAPIA (2014)
Intestinal and Hepatic Expression of Cytochrome P450s and mdr1a in Rats with Indomethacin-Induced Small Intestinal Ulcers
Shoji Kawauchi et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)
Cucurbitacin IIa induces caspase-3-dependent apoptosis and enhances autophagy in lipopolysaccharide-stimulated RAW 264.7 macrophages
Jian He et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Cucurbitacins - A Promising Target for Cancer Therapy
Abdullah A. Alghasham
INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS (2013)
Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation
Shuai Ren et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats
Cheng-Xue Ji et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats
Fikret Vehbi Izzettin et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2012)
Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
C. Boykin et al.
BRITISH JOURNAL OF CANCER (2011)
Natural products and their role in cancer therapy
David Siu
MEDICAL ONCOLOGY (2011)
Recent advances in proton pump inhibitors and management of acid-peptic disorders
Kishor S. Jain et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Anticancer activity of Hemsleya amabilis extract
J Wu et al.
LIFE SCIENCES (2002)
The novel structure of a disaccharide derivative from Hemsleya amabilis
YK Yang et al.
TETRAHEDRON (2000)